Skip to menu Skip to content Skip to footer

A Multicentre, Parallel Group Open-label Randomised Controlled Non-Inferiority Phase 3 Trial, of ceftolozane-tazobactam versus meropenem for definitive treatment [...] MERINO-3 (2019-2022)

Experts

Dr Patrick Harris

NHMRC Emerging Leadership Fellow
UQ Centre for Clinical Research
Faculty of Medicine
Associate Professor, Infectious Diseases
Faculty of Medicine
Patrick Harris
Patrick Harris